1/94
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
Signs and Symptoms of Parkinson Disease: Motor Symptoms
Tremor (resting tremor)
Bradykinesia (slowness of movement)
Rigidity (muscle stiffness)
Postural instability (balance problems)
Signs and Symptoms of Parkinson Disease: Non-Motor Symptoms
Cognitive impairment
Mood disorders (depression, anxiety)
Sleep disturbances
Autonomic dysfunction (e.g., constipation, orthostatic hypotension)
Neurotransmitter Imbalance in Parkinson’s
Deficient Neurotransmitter:
Dopamine
Role of Dopamine: a crucial neurotransmitter involved in regulating movement, motivation, and reward. It is primarily produced in the substantia nigra and affects the basal ganglia, which are critical for motor control
Excess Neurotransmitter:
Acetylcholine
Role of Acetylcholine: Another important neurotransmitter involved in muscle activation, learning, and memory. It is released at neuromuscular junctions and in various brain regions
Parkinson’s - Deficiency in Dopamine - Motor Symptoms
A deficiency in dopamine, as seen in conditions like Parkinson’s disease, leads to motor symptoms, such as:
bradykinesia (slowness of movement)
rigidity
tremors
postural instability
This occurs because the basal ganglia cannot properly regulate movement without adequate dopamine
Parkinson’s - Deficiency in Dopamine - Non-Motor Symptoms
Dopamine deficiency can also cause non-motor symptoms, including:
depression
cognitive impairment
autonomic dysfunction (e.g., constipation, orthostatic hypotension)
Parkinson’s - Excess Acetylcholine - Motor Symptoms
When dopamine levels are low, the relative excess of acetylcholine in the basal ganglia exacerbates motor symptoms. This imbalance can lead to increased:
muscle rigidity
tremors
…because acetylcholine promotes muscle contraction
Parkinson’s - Excess Acetylcholine - Non-Motor Symptoms
Excess acetylcholine can also affect cognitive functions, potentially leading to symptoms, such as:
confusion
memory problems
Imbalance Effects of Dopamine and Acetylcholine - Motor Symptoms
The imbalance between deficient dopamine and excess acetylcholine disrupts the normal functioning of the basal ganglia, leading to the characteristic motor symptoms of Parkinson’s disease and similar disorders
The lack of dopamine means that inhibitory signals are reduced, while the excess acetylcholine increases excitatory signals, resulting in impaired movement control
Imbalance Effects of Dopamine and Acetylcholine - Non-Motor Symptoms
The imbalance can also contribute to non-motor symptoms by affecting other brain regions involved in mood, cognition, and autonomic functions
Example: reduced dopaminergic activity can lead to depression and cognitive decline, while the cholinergic overactivity can cause autonomic disturbances
Action of Carbidopa-Levodopa
Levodopa:
Precursor to dopamine that crosses the blood-brain barrier
Converted to dopamine in the brain
Carbidopa:
Inhibits peripheral conversion of levodopa to dopamine
Increases availability of levodopa to the brain
Clinical Use:
Most effective treatment for motor symptoms of Parkinson Disease
What is levodopa?
Precursor to dopamine that crosses the blood-brain barrier
Converted to dopamine in the brain
What is carbidopa?
Inhibits peripheral conversion of levodopa to dopamine
Increases availability of levodopa to the brain
What is the clinical use of carbidopa-levodopa?
Most effective treatment for motor symptoms of Parkinson Disease
Action of Dopamine Agonists
Mechanism of Action:
Mimic dopamine by stimulating dopamine receptors in the brain
Examples:
Pramipexole
Ropinirole
Rotigotine
Clinical Use:
Used as monotherapy in early stages or in combination with levodopa in advanced stages
What is the clinical use of dopamine agonists?
Used as monotherapy in early stages or in combination with levodopa in advanced stages
Action of Entacapone and Opicapone
Mechanism of Action:
Catechol-O-methyltransferase (COMT) inhibitors
Prevent breakdown of levodopa in the periphery
Clinical Use:
Prolong the effect of levodopa
Reduce “off” periods in patients with fluctuating response to levodopa
What is the clinical use of entacapone and opicapone?
Prolong the effect of levodopa
Reduce “off” periods in patients with fluctuating response to levodopa
Action of Monoamine Oxidase Inhibitors (MAOIS)
Mechanism of Action:
Inhibit monoamine oxidase-B (MAO-B) enzyme
Prevent breakdown of dopamine in the brain
Examples:
Selegiline
Safinamide
Rasagiline
Clinical Use:
Used as monotherapy in early stages or as adjunct therapy in advanced stages
Anticholinergic Agents in Parkinson Disease
Mechanism of Action:
Block acetylcholine receptors
Reduce the relative excess of acetylcholine
Clinical Use:
Improve tremor and rigidity
Less effective for bradykinesia
Symptoms Improved by Anticholinergic Agents
Specific Symptoms:
Reduction in tremor
Decrease in muscle rigidity
“better QoL”
Patient Considerations:
Use with caution in elderly patients due to risk of cognitive side effects
Agents Used in the Treatment of Alzheimer Disease
Cholinesterase Inhibitors
Mechanism:
Inhibit breakdown of acetylcholine, enhancing cholinergic transmission
Examples:
Donepezil
Rivastigmine
Galantamine
NMDA Receptor Antagonists
Mechanism:
Modulates glutamate activity to prevent excitotoxicity
Example:
Memantine
Action of Cholinesterase Inhibitors
Mechanism of Action:
Inhibit acetylcholinesterase enzyme
Increase levels of acetylcholine in the brain
Clinical Use:
Improve cognitive function and slow progression of symptoms in mild to moderate Alzheimer disease
What is the clinical use of cholinesterase inhibitors?
Improve cognitive function and slow progression of symptoms in mild to moderate Alzheimer disease
Action of NMDA Receptor Antagonists
Mechanism of Action:
Block NMDA receptors to reduce glutamate-mediated excitotoxicity
Clinical Use:
Used in moderate to severe Alzheimer disease
Can be used in combination with cholinesterase inhibitors
What is the clinical use of NMDA Receptor Antagonists?
Used in moderate to severe Alzheimer disease
Can be used in combination with cholinesterase inhibitors
Generalized Anxiety Disorder (GAD)
Definition:
Excessive, uncontrollable worry about various aspects of life
Symptoms:
Restlessness
Fatigue
Difficulty concentrating
Irritability
Muscle tension
Sleep disturbances
Duration:
Symptoms present for at least 6 months
Panic Disorder
Definition:
Recurrent, unexpected panic attacks
Symptoms:
Palpitations, sweating, trembling, SOB, chest pain, dizziness, fear of losing control or dying
Duration:
Persistent concern about having more attacks or significant behavioral changes for at least 1 month
Phobias
Definition:
Intense, irrational fear of specific objects or situations
Types:
Specific phobias (e.g., fear of heights, animals)
Social phobia (social anxiety disorder)
Agoraphobia (fear of open or crowded spaces)
Symptoms:
Avoidance behavior, intense anxiety when exposed to the phobic stimulus
Obsessive-Compulsive Disorder (OCD)
Definition:
Presence of obsessions (intrusive, unwanted thoughts) and/or compulsions (repetitive behaviors or mental acts)
Symptoms:
Obsessions (e.g., fear of contamination)
Compulsions (e.g., excessive handwashing)
Impact:
Significant distress and impairment in daily functioning
Comparison of Anxiety Disorders: GAD vs. Panic Disorder
GAD: Chronic worry, no specific triggers
Panic Disorder: Sudden, intense panic attacks
Comparison of Anxiety Disorders: Phobias vs. OCD
Phobias: Fear of specific objects/situations
OCD: Obsessions and compulsions
Baseline Assessment of Mental Status
Appearance:
General appearance, grooming, hygiene
Behavior:
LOC, eye contact, motor activity
Mood and Affect:
Patient’s reported mood, observed affect
Thought Processes:
Coherence, logic, relevance of thoughts
Thought Content:
Presence of delusions, obsessions, phobias
Cognition:
Orientation, memory, attention, concentration
Insight and Judgment:
Awareness of condition, decision-making ability
Drug Therapy for Anxiety Disorders
Benzodiazepines
Selective Serotonin Reuptake Inhibitors (SSRIs)
Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
Drug Therapy for Anxiety Disorders: Benzodiazepines
Mechanism:
Enhance GABA activity
Use:
Short-term relief of acute anxiety symptoms
Examples:
Diazepam
Lorazepam
Alprazolam
Drug Therapy for Anxiety Disorders: Selective Serotonin Reuptake Inhibitors
Mechanism:
Increase serotonin levels in the brain
Use:
Long-term management of anxiety disorders
Examples:
Setraline
Fluoxetine
Escitalopram
Drug Therapy for Anxiety Disorders: Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
Mechanism:
Increase serotonin and norepinephrine levels
“norepinephrine mediates fight or flight response”
Use:
Long-term management of anxiety disorders
“also used for combo anxiety+depression management, but cause overwhelming fatigue”
Examples:
Venlafaxine
Duloxetine
Adverse Effects of Anxiety Medications: Benzodiazepines
Sedation
Dizziness
Dependence
Withdrawal Symptoms
Adverse Effects of Anxiety Medications: SSRIs
Nausea
Insomnia
Sexual dysfunction
Weight gain
Adverse Effects of Anxiety Medications: SNRIs
Nausea
Dry mouth
Increased BP
Sexual dysfunction
Psychological and Physiologic Drug Dependence
Psychological Dependence:
Craving for the drug, compulsive use despite negative consequences
Physiologic Dependence:
Tolerance (need for higher doses to achieve the same effect)
Withdrawal symptoms upon discontinuation
Management:
Gradual tapering of the drug
Supportive therapy and counseling
What is the definition of baseline assessment?
A comprehensive evaluation conducted before starting treatment to understand the patient’s current health status
What is the importance of baseline assessments?
Crucial for treatment planning as they provide a reference point to measure progress and identify any pre-existing conditions that may affect treatment
Baseline Assessment Components: Medical History
Includes a detailed review of the patient’s past and present medical and psychiatric conditions, family history, and any previous treatments
Baseline Assessment Components: Physical Examination
Key checks include vital signs, body mass index (BMI), and a general physical health assessment to identify any underlying conditions
Baseline Assessment Components: Mental Status Examination
Evaluates cognitive functions, mood, thought processes, and behavior to understand the patient’s mental health status
Baseline Assessment Components: Laboratory Tests
Relevant tests may include thyroid function tests, complete blood count (CBC), liver function tests, and other specific tests based on the patient’s history
Baseline Assessment for Depression
Specific Assessments:
Tools like the Patient Health Questionnaire-9 (PHQ-9) are used to quantify the severity of depression
Symptom Evaluation:
Assess the severity, duration, and impact of depressive symptoms on daily life, including sleeping patterns, appetite, and energy levels
Baseline Assessment for Bipolar Disorder
Specific Assessments:
Tools such as the Mood Disorder Questionnaire (MDQ) help identify symptoms of mania and hypomania
Symptom Evaluation:
Evaluate the frequency, duration, and intensity of manic, hypomanic, and depressive episodes, and their impact in the patient’s functioning
What is the definition of Premedication Assessments?
Evaluations conducted before starting a new medication to ensure it is safe and appropriate for the patient
What is the importance of Premedication Assessments?
Help prevent adverse reactions and ensure the chosen medication will be effective
Premedication Assessments for MAOIs
Medical History:
Review for contraindications such as hypertension and dietary restrictions due to potential interactions with certain foods
Physical Examination:
Monitor BP to detect any pre-existing HTN
“↑dopamine = ↑BP, use cautiously”
Laboratory Tests:
Conduct liver function tests to ensure the liver can metabolize the medication safely
Premedication Assessments for SSRIs and SNRIs
Medical History:
Assess previous responses to SSRIs/SNRIs and review other medications to avoid interactions
Physical Examination:
Check weight and BP as these medications can affect both
Laboratory Tests:
Evaluate electrolytes and renal function to ensure safe medication use
Premedication Assessments for TCAs
Medical History:
Review cardiac history, glaucoma, and urinary retention as TCAs can exacerbate these conditions
Physical Examination:
Perform an ECG to assess cardiac health
Laboratory Tests:
Check blood glucose and liver function to monitor for potential side effects
Premedication Assessments for Anti-Manic Agents
Medical History:
Assess renal and thyroid function as these medications can affect both
“lithium and thyroid go hand in hand”
Physical Examination:
Monitor weight and BP regularly
Laboratory Tests:
Conduct serum electrolyte and renal function tests to ensure safe use
Common Adverse Effects of MAOIs
Hypertensive Crisis:
Symptoms include severe headache, chest pain, and palpitations; management involves immediate medical attention
Dietary Restrictions:
Avoid foods high in tyramine, such as aged cheeses and cured meats
Other Effects:
Insomnia, dizziness, and weight gain are common side effects
Common Adverse Effects of SSRIs and SNRIs
Gastrointestinal Issues:
Nausea and diarrhea are common, especially when starting treatment
Sexual Dysfunction:
Includes decreased libido and difficulty achieving orgasm
Other Effects:
Insomnia, headache, and weight changes can occur
Common Adverse Effects of TCAs
Cardiovascular Effects:
Includes arrhythmias and hypotension, which requires monitoring
Anticholinergic Effects:
Dry mouth, constipation, and urinary retention are common
Other Effects:
Weight gain and sedation can also occur
Common Adverse Effects of Lithium
*NCLEX (Most common for Bipolar)
Renal Effects:
Polyuria (increased urination) and polydipsia (increased thirst) are common
“look for electrolyte disturbances”
“lithium is metabolized in kidneys”
Thyroid Effects:
Hypothyroidism can develop, requiring regular thyroid function tests
Other Effects:
Tremor, weight gain, and GI issues like nausea
Introduction to Psychotic Behavior
Psychosis is a mental disorder characterized by a disconnection from reality, often involving hallucinations and delusions
Prevalence:
Psychosis affects approximately 3% of the population at some point in their lives
Signs and Symptoms of Psychotic Behavior
Positive Symptoms:
Hallucinations (seeing or hearing things that aren’t there)
Delusions (false beliefs)
Disorganized thinking
Negative Symptoms:
Affective flattening (reduced emotional expression)
Alogia (poverty of speech)
Anhedonia (inability to feel pleasure)
Cognitive Symptoms:
Impaired executive function, attention deficits, and memory problems
Major Indications for Anti-Psychotic Agents
Schizophrenia:
Primary indication for both acute and maintenance treatment
Bipolar Disorder:
Used to manage manic and mixed episodes
Other Indications:
Severe depression with psychotic features
Other psychotic disorders
Agitation in various conditions
First-Generation Antipsychotics (FGAs)
Mechanism of Action:
Primarily block dopamine D2 receptors
Indications:
Effective for acute psychosis and chronic schizophrenia
Examples:
Haloperidol
“Nursing consideration → will increase QT interval → rarely given IV Push (could cause cardiac arrest) → USE IM”
Chlorpromazine
Second-Generation Antipsychotics (SGAs)
Mechanism of Action:
Block both dopamine and serotonin receptors
Indications:
Used for schizophrenia, bipolar disorder, and as adjuncts in depression
“more commonly used for long-term control”
Examples:
risperidone
olanzapine
quetiapine (“good for delirium; Seroquel”)
Comparison of FGAs and SGAs
Efficacy:
SGAs are generally preferred due to better side effect profiles and efficacy in treating both positive and negative symptoms
Side Effects:
FGAs are more likely to cause extrapyramidal symptoms (EPS), while SGAs are associated with metabolic side effects like weight gain and diabetes
Common Adverse Effects of FGAs
Extrapyramidal Symptoms:
Tardive dyskinesia (involuntary movements)
Akathisia (restlessness)
Dystonia (muscle contractions)
***NCLEX ↑ “reason SGAs created”
Other Effects:
Sedation
Anticholinergic effects (dry mouth, constipation)
Orthostatic hypotension (drop in BP when standing)
Common Adverse Effects of SGAs
Metabolic Syndrome:
Includes weight gain, diabetes, and dyslipidemia (abnormal lipid levels)
Other Effects:
Sedation
QT prolongation (heart rhythm changes)
Agranulocytosis (severe drop in WBCs) with clozapine
Monitoring and Management of Adverse Effects of SGAs
Regular Monitoring:
Includes weight, glucose levels, and lipid profiles to detect early signs of metabolic syndrome
Management Strategies:
May involve dose adjustments, switching medications, or adding treatments to manage side effects
Special Considerations in Antipsychotic Use
Elderly Patients:
Increased risk of cerebrovascular events and mortality, requiring careful monitoring
“higher risk of stroke”
Pregnancy and Lactation:
Weighing risks vs. benefits, with some medications preferred due to lower risk profiles
“antipsychotics can affect fetus”
Introduction to Seizure Disorders
Definition:
Also known as epilepsy
A group of neurological disorders characterized by recurrent, unprovoked seizures
Prevalence:
Approximately 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally
Types of Seizure Disorders: Generalized Seizures
Affect both sides of the brain and can cause loss of consciousness
Types:
Tonic-clonic
Absence
Myoclonic
Atonic
Types of Seizure Disorders: Focal Seizures
Originate in one area of the brain and can be classified based on the level of awareness during the seizure
Types:
Focal aware
Focal impaired awareness
Types of Seizure Disorders: Unknown Onset Seizures
Are those where the beginning of the seizure is not witnessed or is unclear
Nursing Interventions During Seizure Activity
Immediate Actions: Ensuring safety, timing the seizure
Ensure the patient’s safety by clearing the area of any potential hazards and timing the duration of the seizure
Post-Seizure Care: Monitoring, documentation, patient reassurance
Monitor the patient’s vital signs
Document the seizure activity
Provide reassurance and support to the patient
Seizure Precautions: Padded side rails, bed in lowest position
Implement seizure precautions such as padded side rails and keeping the bed in the lowest position to prevent injury
Desired Therapeutic Outcomes from Anti-Epileptic Agents
Seizure Control: Reduction in frequency and severity
Primary goal is to achieve optimal seizure control with minimal side effects
Quality of Life: Improved daily functioning and independence
Improving the patient’s quality of life by enhancing daily functioning and promoting independence
“pts with uncontrolled seizures cannot drive”
Minimizing Adverse Effects: Balancing efficacy with tolerability
Balancing the efficacy of anti-epileptic agents with their tolerability to minimize adverse effects
Drug Classes Used to Treat Seizure Disorders - Overview
Hydantoins
Barbiturates
Benzodiazepines
Succinimides
Others: Valproic acid (Depakene), lamotrigine (Lamictal)
Drug Classes Used to Treat Seizure Disorders: Hydantoins
Used to control generalized tonic-clinic seizures
Example: Phenytoin (Dilantin)
Drug Classes Used to Treat Seizure Disorders: Barbiturates
Enhance GABA activity and are used for generalized and partial seizures
Example: Phenobarbital
Drug Classes Used to Treat Seizure Disorders: Benzodiazepines
Increase GABAergic inhibition and are used for acute seizure management and status epilepticus
Examples: diazepam (Valium), lorazepam (Ativan)
Drug Classes Used to Treat Seizure Disorders: Succinimides
Reduce T-type calcium currents and are used for absence seizures
Example: ethosuximide (Zarontin)
Drug Classes Used to Treat Seizure Disorders: Valproic acid (Depakene) & lamotrigine (Lamictal)
Used for various types of seizures and have different mechanisms of action
For Seizures: Hydantoins
Mechanism of Action:
Work by stabilizing neuronal membranes and decreasing excitability
Common Uses:
Commonly used for managing generalized tonic-clonic seizures
Adverse Effects:
Gingival hyperplasia (overgrowth of gum tissues)
Nystagmus (involuntary eye movement)
For Seizures: Barbiturates
Mechanism of Action:
Enhance the activity of GABA, an inhibitory neurotransmitter, which helps to calm neuronal activity
“inhibit brain waves; not used as commonly”
Common Uses:
Used for both generalized and partial seizures
Adverse Effects:
Sedation and cognitive impairment, which can affect daily functioning
For Seizures: Benzodiazepines
Mechanism of Action:
Increase GABAergic inhibition, which helps to reduce neuronal excitability
Common Uses:
Used for acute seizure management and in the treatment of status epilepticus
Adverse Effects:
Drowsiness
Development of tolerance with long-term use
For Seizures: Succinimides
Mechanism of Action:
Work by reducing T-type calcium currents in the brain
“reduce excitability”
Common Uses:
Are primarily used to treat absence seizures
Adverse Effects:
GI distress
Fatigue
Neurologic Assessment for Anti-Epileptic Agents
Baseline Assessment:
Conduct a baseline assessment of the patient’s cognitive function and mood before starting treatment
Ongoing Monitoring:
Perform regular neuropsychological evaluations to monitor the patient’s response to treatment
Adverse Effects:
Monitor for any cognitive and behavioral changes that may indicate adverse effects of the medication
“many contraindicated in pregnancy”
Pain Assessment for Patients Receiving Opiate Agonists
Initial Assessment:
Conduct an initial assessment of the patient’s pain history, including intensity (using scales like VAS or NRS), location, quality, and duration
Ongoing Monitoring:
Regularly reassess the patient’s pain, monitor for side effects, and evaluate the functional impact of the pain and treatment
“look for respiratory depression, ↓BP/HR
Properties of Opiate Full Agonists
Full Agonists:
Bind fully to opioid receptors (e.g., morphine, fentanyl), providing strong analgesic effects
Mechanism of Action:
Activate mu receptors, leading to analgesia, euphoria, and potential respiratory depression
Properties of Opiate Partial Agonists
Partial Agonists:
Bind partially to opioid receptors (e.g., buprenorphine), providing analgesia with a ceiling effect on respiratory depression
“kills pain, but it has a built-in safety limit on how much it can slow your breathing”
Mechanism of Action:
Partial activation
Provide pain relief with a lower risk of respiratory depression compared to full agonists
Properties of Opiate Antagonists
Antagonists:
Block opioid receptors (e.g., naloxone aka Narcan), preventing activation by agonists
Mechanism of Action:
Used to reverse the effects of opioid overdose by blocking the receptors
Common Adverse Effects of Opiate Agonists
Gastrointestinal:
Nausea, vomiting, and constipation
Central Nervous System:
Sedation
Dizziness
Respiratory depression
Other Effects:
Include the development of physical dependence and tolerance with long-term use
Opiate Antagonists and Therapeutic Outcomes
Naloxone:
Used to reverse opioid overdose by blocking opioid receptors
Monitoring:
Monitor the patient’s RR, consciousness level, and withdrawal symptoms after administration
Introduction to Salicylates
Definition:
Are derivatives of salicylic acid with analgesic, antipyretic, and anti-inflammatory properties
“antipyretic = reduce fever”
Common Examples:
aspirin
salsalate
Pharmacologic Effects of Salicylates
Analgesic Effect:
Provide pain relief by inhibiting the synthesis of prostaglandins
Antipyretic Effect:
Reduction of fever by acting on the hypothalamus
Anti-Inflammatory Effect:
Decrease in inflammation by inhibiting cyclooxygenase (COX) enzymes
Common Adverse Effects of Salicylates
Gastrointestinal:
Common GI side effects include gastric irritation, ulcers, and bleeding
“HUGE for long-term use → MONITOR”
Renal:
Long-term use can impair kidney function
Other Effects:
Include tinnitus and the risk of Reye’s syndrome in children
“not given for children under 18”
“Reye’s syndrome = a rare but serious, rapidly progressing condition causing brain swelling and liver damage in children (often aged 4–12), typically occurring 3–7 days after a viral infection like influenza or chickenpox”
Serious Adverse Effects and Drug Interactions of Salicylates
Serious Effects:
Gastrointestinal bleeding
Renal impairment
Drug Interactions:
Can increase the risk of bleeding when taken with anticoagulants and reduce the efficacy of antihypertensives